The Global Elastography Imaging Market Size is valued at 2.26 billion in 2023 and is predicted to reach 3.98 billion by the year 2031 at a 7.4% CAGR during the forecast period for 2024-2031.
The demand for less invasive medical procedures is expected to increase significantly between 2023 and 2032, which would boost the market for elastography imaging. A non-invasive medical imaging procedure called elastography is used to assess the body's organs' and other structures' rigidity. The speed at which vibrations go through the organs is examined using ultrasound or magnetic resonance imaging.
The elasticity or stiffness of the liver and other organs including the thyroid, breast, and prostate are then visualized using this data. It is anticipated that as the prevalence of chronic diseases including cardiovascular disease, obstetrics/gynecology, urology, and others rises, so will the demand for minimally invasive procedures. Potential uses for elastography include the early diagnosis of tumors. It can be used successfully to precisely find small gland nodules. As a result, elastography is anticipated to be used more frequently in preventative healthcare.
The market is anticipated to grow over the projected period as a result of an increase in the number of active studies evaluating prospective uses of elastography. Numerous of this research also examine ophthalmic applications, such as oculomotor muscle characterization and corneal mechanical property evaluation.
The Elastography Imaging market is segmented on the basis of modality, application, and end-user. The modality segment includes ultrasound and magnetic resonance. The application segment includes Radiology/general imaging, OB/GYN, cardiology, urology, vascular, orthopedic and musculoskeletal applications, and Other applications. The end-user segment includes hospitals, surgical centers, diagnostic centers, ambulatory surgical centers, and other end-users.
Due to characteristics like easy accessibility, rapid turnaround times, and easy pricing, the ultrasound segment is predicted to dominate the market. A gradual replacement for conventional ultrasound devices used for organ inspection and biopsy is ultrasonic elastography. During the projected period, such imaging equipment's painless, accurate diagnostic imaging is anticipated to help the market grow. The rising incidence of breast cancer among women is anticipated to raise demand for sonographic imaging, which can reveal breast lesions, as well as for ultrasound elastography imaging devices, which will propel market expansion.
Due to the growing usage of elastography in radiology ultrasound and image-guided radiotherapy, the radiology segment is predicted to dominate the elastography imaging market in the years to come. Cancer diagnosis and/or treatment, abdominal conditions, and soft tissue injuries are among the general imaging applications of radiology.
Due to the presence of numerous international companies, North America is predicted to hold the largest share of the elastography imaging market throughout the forecast period. Besides, the regional market is being driven by manufacturers' increased commercialization efforts and end users' expanding importance of using these systems in various nations. Over the projection period, Asia Pacific is anticipated to experience consistent growth as well.
The regional market is anticipated to be pushed by aspects like an ageing population, better healthcare services, and swift economic expansion. Due to the quick development of healthcare facilities, countries like China, Japan, and India have made a significant contribution to growth in the Asia Pacific region. Additionally, growing public knowledge of the therapeutic potential of ultrasound technology and the precise and quick results offered by these devices is helping the local market.
| Report Attribute | Specifications |
| Market size value in 2023 | USD 2.26 Bn |
| Revenue forecast in 2031 | USD 3.98 Bn |
| Growth rate CAGR | CAGR of 7.4% from 2024 to 2031 |
| Quantitative units | Representation of revenue in US$ Billion, and CAGR from 2024 to 2031 |
| Historic Year | 2019 to 2023 |
| Forecast Year | 2024-2031 |
| Report coverage | The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends |
| Segments covered | Modality, Application, And End-User |
| Regional scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | CANON MEDICAL SYSTEMS CORPORATION, Esaote SpA, Fujifilm Corporation, GE Healthcare, Supersonic Imagine, Hologic, Inc, Koninklijke Philips N.V., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Resoundant, Inc., and Siemens |
| Customization scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing and available payment methods | Explore pricing alternatives that are customized to your particular study requirements. |
Elastography Imaging Market By Modality-
Elastography Imaging Market By Application-
Elastography Imaging Market By End-User-
Elastography Imaging Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.